Literature DB >> 10227048

Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai.

Z Chen1, W Zheng, L J Custer, Q Dai, X O Shu, F Jin, A A Franke.   

Abstract

Soy foods and certain soy constituents, particularly isoflavones, have been suggested to have potential cancer-inhibitory effects in laboratory and epidemiological studies. Chinese women in Shanghai consume high levels of soy foods and have low incidence rates of breast and other hormone-related cancers. To assess the usual dietary consumption of soy foods and evaluate the correlation of soy food consumption with the urinary excretion of isoflavonoids in overnight urine samples in this population, we analyzed data from 60 healthy women included in an ongoing population-based case-control study of breast cancer in Shanghai. Usual consumption of soy foods in the previous five-year period was assessed using a food-frequency questionnaire, and urinary excretion of daidzein, genistein, glycitein, equol, and O-desmethylangolensin was measured from overnight urine samples collected at the time of dietary assessment. Virtually all women (96.7%) in Shanghai consumed soy foods at least once a week. The median intake of soy food was 100.6 g/day, with 25th and 75th percentiles of 36.8 and 238.2 g, respectively. The median intake of isoflavones was 39.26 mg/day, and there was a nearly fourfold difference between the 25th and 75th percentiles of this measurement. With the increasing intake of soy foods, urinary excretion rates of total isoflavonoids and all individual major isoflavonoids were increased in a dose-response manner (trend test p < or = 0.05). At individual levels the urinary excretion rate of total isoflavonoids was correlated closely with dietary soy food intake, with a correlation coefficient of around 0.5 (p < 0.001). These results indicate that the urinary excretion rate of total isoflavonoids measured from overnight urine samples may reflect reasonably well the usual intake of soy foods in a population with a high level of soy food consumption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227048     DOI: 10.1080/01635589909514752

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  38 in total

Review 1.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-12

2.  Isoflavones - Mechanism of Action and Impact on Breast Cancer Risk.

Authors:  Johannes Stubert; Bernd Gerber
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

Review 3.  Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.

Authors:  Annette J Thomas; Rita Ismail; Lisa Taylor-Swanson; Lori Cray; Janet G Schnall; Ellen Sullivan Mitchell; Nancy Fugate Woods
Journal:  Maturitas       Date:  2014-05-28       Impact factor: 4.342

Review 4.  Role of phytoestrogens in prevention and management of type 2 diabetes.

Authors:  Mohammad Talaei; An Pan
Journal:  World J Diabetes       Date:  2015-03-15

5.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

6.  Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women.

Authors:  Cornelia Charles; Julia Yuskavage; Olga Carlson; Majnu John; Arlene S Tagalicud; Marcello Maggio; Denis C Muller; Josephine Egan; Shehzad Basaria
Journal:  Menopause       Date:  2009 Mar-Apr       Impact factor: 2.953

7.  The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

Authors:  Kenneth Dr Setchell; Xueheng Zhao; Pinky Jha; James E Heubi; Nadine M Brown
Journal:  Am J Clin Nutr       Date:  2009-08-26       Impact factor: 7.045

8.  Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study.

Authors:  Wang Hong Xu; Wei Zheng; Yong Bing Xiang; Zhi Xian Ruan; Jia Rong Cheng; Qi Dai; Yu Tang Gao; Xiao Ou Shu
Journal:  BMJ       Date:  2004-05-10

9.  Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial.

Authors:  Elena A Pop; Leslie M Fischer; April D Coan; Matt Gitzinger; Jun Nakamura; Steven H Zeisel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

10.  Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.

Authors:  S-Y Park; L R Wilkens; A A Franke; L Le Marchand; K K Kakazu; M T Goodman; S P Murphy; B E Henderson; L N Kolonel
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.